T1	Participants 71 119	patients with poorly controlled type 2 diabetes.
T2	Participants 195 232	patients with type 2 diabetes (T2DM).
T3	Participants 299 416	subjects treated for T2DM with metformin ± sulphonylurea, who had glycated haemoglobin (HbA1c) levels of 7.5-12%
T4	Participants 733 737	<7%.
T5	Participants 738 943	RESULTS The mean [standard deviation (s.d.)] age of the participants was 57 (9) years, the duration of diabetes was 9 (6) years, body mass index was 31.9 (4.2) kg/m(2) and HbA1c level was 9.0 (1.1)%.
T6	Participants 944 957	Equal numbers
T7	Participants 990 1015	glargine and liraglutide.
T8	Participants 1016 1043	Similar numbers of subjects
T9	Participants 1168 1192	observed (p = 0.44).
T10	Participants 1193 1201	Subjects
T11	Participants 1385 1412	those receiving liraglutide
T12	Participants 1830 1847	CONCLUSION Adding
